Literature DB >> 9522362

Adenosine A2 receptors modulate hippocampal synaptic transmission via a cyclic-AMP-dependent pathway.

K Kessey1, D J Mogul.   

Abstract

Blockade of adenosine A2 receptors has been shown to significantly reduce the level of tetanus-induced long-term potentiation in area CA1 of rat hippocampus [Kessey K. et al. (1997) Brain Res. 756, 184-190; Sekino Y. et al. (1991) Biochem. biophys. Res. Commun. 181, 1010-1014]. In the present study, the effects of A2 receptor activation and blockade on the modulation of normal synaptic transmission and tetanus-induced long-term potentiation were examined at the Schaffer-CA1 synapse in rat hippocampal slices. A2 receptor activation reversibly enhanced synaptic transmission evoked by low-frequency test pulses as measured by the dendritic field excitatory postsynaptic potential. In the presence of A1 receptor blockade, A2 activation further enhanced the excitatory postsynaptic potential, while A2 receptor blockade resulted in a reversible decrease of the excitatory postsynaptic potential. The A2a receptor agonist, CGS21680, had no effect on the excitatory postsynaptic potential, suggesting that tonic activation of A2b receptors contributes to synaptic transmission under normal physiological conditions. Furthermore, we investigated the contribution of A2 receptors to the level of tetanus-induced long-term potentiation. Under control conditions, a single tetanus potentiated the excitatory postsynaptic potential by 63.5% relative to baseline 30 min post-tetanus. In contrast, tetanus-induced long-term potentiation during A2 blockade was 21.3%. A2 receptor activation increased the level of tetanus-induced long-term potentiation to 90.2%. Because A2 receptors are known to stimulate cyclic-AMP accumulation, the possible involvement of cyclic-AMP was examined. Forskolin, a direct adenylate cyclase activator, and 8-bromo-cyclic-AMP, a membrane-permeable analog of cyclic-AMP, were able to reconstitute tetanus-induced long-term potentiation during A2 receptor blockade; however, the inactive analog 1,9-dideoxyforskolin had no effect, indicating that the effects of A2 activation on synaptic transmission were mediated largely through the regulation of intracellular cyclic-AMP. Because A1 receptors exert an opposing effect on synaptic transmission relative to A2 receptors, these results suggest that the stoichiometry of A1 versus A2 receptor activation appears to play an important role in the modulation of normal synaptic transmission and long-term potentiation in the CA1 region of the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9522362     DOI: 10.1016/s0306-4522(97)00504-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

Review 1.  Caffeine and the control of cerebral hemodynamics.

Authors:  Dale A Pelligrino; Hao-Liang Xu; Francesco Vetri
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Adenosine-mediated presynaptic modulation of glutamatergic transmission in the laterodorsal tegmentum.

Authors:  E Arrigoni; D G Rainnie; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

3.  Modulatory effects of adenosine on inhibitory postsynaptic potentials in the lateral amygdala of the rat.

Authors:  T Heinbockel; H C Pape
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Gamma-aminobutyric acid type A receptors modulate cAMP-mediated long-term potentiation and long-term depression at monosynaptic CA3-CA1 synapses.

Authors:  T P Yu; S McKinney; H A Lester; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Subchronic treatment with methamphetamine and phencyclidine differentially alters the adenosine A1 and A2A receptors in the prefrontal cortex, hippocampus, and striatum of the rat.

Authors:  Y Shirayama; K Hashimoto; T Higuchi; Y Minabe
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

6.  A1 adenosine receptors inhibit multiple voltage-gated Ca2+ channel subtypes in acutely isolated rat basolateral amygdala neurons.

Authors:  B A McCool; J S Farroni
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

7.  Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity.

Authors:  Oscar P Dall'Igna; Lisiane O Porciúncula; Diogo O Souza; Rodrigo A Cunha; Diogo R Lara; Oscar P Dall'lgna
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Species comparison of adenosine receptor subtypes in brain and testis.

Authors:  Gino Giannaccini; Laura Betti; Lionella Palego; Laura Fabbrini; Lara Schmid; Maura Castagna; Laura Giusti; Giovanni Mascia; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2007-11-07       Impact factor: 3.996

9.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study.

Authors:  Fatemeh Kermanian; Mehdi Mehdizadeh; Mansureh Soleimani; Ali Reza Ebrahimzadeh Bideskan; Majid Asadi-Shekaari; Hamed Kheradmand; Hossein Haghir
Journal:  Metab Brain Dis       Date:  2012-09-09       Impact factor: 3.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.